FDA Investigator Karen A Briggs
Karen A Briggs has inspections in 1 countries as of 26 Sep 2023. Karen A Briggs has collaborated with a combinined 2578 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
13
Last Inspection Date:
26 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Amy C Jordan,
Amy Chen,
Amy N Chen,
Anastasia I Offordile,
Anastasia M Shields,
Anita R Michael,
Anne Marie Dubrey,
Annet R Rajan,
Audrey Thereset Uy,
Barbara J Maulfair,
Bijoy Panicker,
Brandy N Lepage,
Brooke K Higgins,
Brooke K Seeman,
Calvin B Koerner,
Candice C Mandera,
Candice J Cortes,
Caroline Strasinger,
Cary Greene,
Christina K Theodorou,
Chryste D Best,
Craig D Zagata,
Cynthia A Palmer,
Dandan Wang, PhD,
Daryl A Dewoskin,
David A Oluwo,
David J Hafner,
Denise L Terzian,
Denise M Digiulio,
Dianne H Milazzo,
Dien N Nguyen,
Donald C Obenhuber, PhD,
Donald G Gordon,
Donald L Lech,
Douglas A Campbell,
Edmund F Mrak, Jr,
Edward D Mcdonald,
Emest F Bizjak,
Eric L Dong, BS,
Erik W Koester,
Frank J Marciniak,
Gayle S Lawson,
Gifford Whitehurst, Jr,
Hala L Selby,
Hala Lj Whetstone,
Jacek Cieslak, PhD,
James A Liubicich,
James M Mason,
James M Simpson,
James P Mcevoy,
Jay T Wong,
Jessica S Estriplet,
Jingbo Xiao,
Joey C West,
Jonathan W Chapman,
Jose E Melendez, DDC,
Jose M Cayuela,
Jose R Hernandez,
Joseph L Despins, PhD,
Julianne C Mccullough,
Julie D Bringger,
Junho Pak,
Keith M Reilly,
Kendra L Brooks,
Kenneth M Gordon,
Ko U Min,
Kristina L Conroy,
Lance M De Souza, MBA,
Lawrence Harmon, Jr,
LCDR Chad N Thompson,
LCDR Debra Emerson,
LCDR Wilfred A Darang,
Lei Zhang, PhD,
Leiyun Boone, PhD,
Li Li,
Liatte Kreuger, PharmD,
Linda M Hoover,
Lisa B Orr,
Lisa M Bellows,
Luella J Rossi,
Luis A Dasta,
Marcelo O Mangalindan, Jr,
Marcus A Ray,
Marea K Harmon,
Margaret E Sarles,
Margaret M Sands,
Maria A Reed,
Maria Joselopez Barragan, PhD,
Maria Keed,
Mark R Mcclain,
Meena Bansal Gupta, PhD,
Megan A Haggerty,
Michael R Klapal,
Michael Shanks, MS,
Michele Gottshall,
Michelle Y Clark Stuart,
Mihaly S Ligmond,
Mindy M Chou,
Monika Borkowska,
Nancy A Saxenian,
Nancy A Saxenian Emmons,
Nancy M Espinal,
Nealie C Newberger,
Nebil A Oumer,
Nicholas A Violand,
Nikki S Ramirez,
Paraluman S Leonin,
Patrick C Klotzbuecher,
Paul L Bellamy,
Qin Xu,
Rachael O Oyewole,
Rajiv R Srivastava,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Robert D Tollefsen,
Robert J Martin,
Robert J Veitch,
Rory K Geyer,
Roseline N Boateng,
Ruark Lanham,
Russell J Glapion,
Saleem A Akhtar,
Sam Pepe,
Sean R Marcsisin,
Sena G Dissmeyer,
Stacey S Degarmo,
Stephen J Koniers,
Steven Fong, MS, PhD,
Sung K Kim,
Susan F Laska, MS,
Tekalign Wondimu,
Thomas E Friel,
Tiffani D Wilson,
Tonia F Bernard,
Vlada Matusovsky,
Wayne E Seifert,
William Hallett, PhD,
William J Leonard,
Yetao Jin, PhD,
Yvesna C Blaise,
Zhao Wang, PhD,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD,
Ziyang Su, PhD
Karen A Briggs's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2023 | FDA 483 | Veranova, L.P. - Form 483, 2023-02-15 |
| June, 2021 | FDA 483 | KVK-TECH, INC. - Form 483, 2021-06-11 |
| June, 2021 | FDA 483 | Granules Pharmaceuticals Inc. - Form 483, 2021-06-25 |
| June, 2023 | FDA 483 | Digestive Care, Inc. - Form 483, 2023-06-27 |
| August, 2022 | FDA 483 | Aarkish Pharmaceuticals NJ Inc - Form 483, 2022-08-18 |
| April, 2023 | FDA 483 | Dimensional Merchandising Inc. - Form 483, 2023-04-18 |
| December, 2022 | FDA 483 | Sentara Infusion Services - Form 483, 2022-12-16 |
| September, 2023 | FDA 483 | Fareva Richmond, Inc. - Form 483, 2023-09-18 |
| March, 2023 | FDA 483 | Safecor Health, LLC - Form 483, 2023-03-16 |
| November, 2023 | FDA 483 | ZOETIS INC - Form 483, 2023-11-17 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more